{{Rsnum
|rsid=7734849
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Orientation=plus
|Chromosome=5
|position=83344130
|Gene=XRCC4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=XRCC4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 0.0 | 21.9 | 78.1
| HCB | 42.2 | 55.6 | 2.2
| JPT | 38.6 | 50.0 | 11.4
| YRI | 27.0 | 46.0 | 27.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 42.2 | 55.6 | 2.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs7734849
|Name_s=
|Gene_s=XRCC4
|Feature=
|Evidence=PubMed ID:18165945
|Annotation=This variant may be associated with risk of developing glioma.
|Drugs=
|Drug Classes=
|Diseases=Glioma
|Curation Level=Curated
|PharmGKB Accession ID=PA161615703
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7734849
|overall_frequency_n=32
|overall_frequency_d=86
|overall_frequency=0.372093
|n_genomes=20
|n_genomes_annotated=0
|n_haplomes=29
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}